The global acute myeloid leukemia (AML) treatment market is expanding as the rising incidence of AML, increasing adoption of targeted therapies and immunotherapies, expanding research initiatives, and improved diagnostic capabilities enhance early detection and treatment outcomes.
The market was valued at approximately USD 3.201 billion in 2024, about USD 3.438 billion in 2025, and is projected...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek